Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 4 (4), 490-9

Spectrum of Myeloid Neoplasms and Immune Deficiency Associated With Germline GATA2 Mutations

Affiliations
Review

Spectrum of Myeloid Neoplasms and Immune Deficiency Associated With Germline GATA2 Mutations

Muhammad A Mir et al. Cancer Med.

Abstract

Guanine-adenine-thymine-adenine 2 (GATA2) mutated disorders include the recently described MonoMAC syndrome (Monocytopenia and Mycobacterium avium complex infections), DCML (dendritic cell, monocyte, and lymphocyte deficiency), familial MDS/AML (myelodysplastic syndrome/acute myeloid leukemia) (myeloid neoplasms), congenital neutropenia, congenital lymphedema (Emberger's syndrome), sensorineural deafness, viral warts, and a spectrum of aggressive infections seen across all age groups. While considerable efforts have been made to identify the mutations that characterize this disorder, pathogenesis remains a work in progress with less than 100 patients described in current literature. Varying clinical presentations offer diagnostic challenges. Allogeneic stem cell transplant remains the treatment of choice. Morbidity, mortality, and social costs due to the familial nature of the disease are considerable. We describe our experience with the disorder in three affected families and a comprehensive review of current literature.

Keywords: GATA2; MonoMAC; leukemia; lymphedema; viral warts.

Figures

Figure 1
Figure 1
Genotype/phenotype relations of GATA2 mutations.
Figure 2
Figure 2
Family Tree of Proband 1 with the GATA2 c.1339A>C.pS447R mutation.
Figure 3
Figure 3
Years post allogeneic HSCT for GATA2 mutation Spinner et al. [53]HSCT, 5 hematopoietic stem cell transplant.

Similar articles

See all similar articles

Cited by 8 PubMed Central articles

See all "Cited by" articles

References

    1. Simon MC. Gotta have GATA. Nat. Genet. 1995;11:9–11. - PubMed
    1. Bresnick EH, Katsumura KR, Lee HY, Johnson KD. Perkins AS. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res. 2012;40:5819–5831. - PMC - PubMed
    1. Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991;349:257–260. - PubMed
    1. Simon MC, Pevny L, Wiles MV, Keller G, Costantini F. Orkin SH. Rescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cells. Nat. Genet. 1992;1:92–98. - PubMed
    1. Weiss MJ. Orkin SH. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl. Acad. Sci. USA. 1995;92:9623–9627. - PMC - PubMed

Substances

Supplementary concepts

Feedback